2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy

Add to Calendar 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy 10/11/2019 7:00:00 AM 10/12/2019 1:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/Toxicities2019 Description: Today, more than 10,000 hematopoietic cell transplantations (HCTs) are performed yearly in the United States as treatment for more than 70 life threatening illnesses including cancers, genetic disorders, and other diseases. Also, given the shift toward cellular therapies in the field of HCT, the number of patients treated with these novel biologic agents is rapidly increasing. Following the successful examples of the i... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY

Date & Location

Friday, October 11, 2019, 7:00 AM - Saturday, October 12, 2019, 1:00 PM, Zuckerman Research Center, 417 East 68th Street

Specialties

Specialties - Bone Marrow Transplant, Cardiology, Cellular Therapeutics, Gastroenterology, Infectious Diseases, Laboratory Medicine, Medical Oncology, Nephrology, Neurology, Oncology and Hematology

Overview

Today, more than 10,000 hematopoietic cell transplantations (HCTs) are performed yearly in the United States as treatment for more than 70 life threatening illnesses including cancers, genetic disorders, and other diseases. Also, given the shift toward cellular therapies in the field of HCT, the number of patients treated with these novel biologic agents is rapidly increasing.

Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, this symposium will bring together experts and thought leaders from around the world in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT and cellular therapies, current advances in the field, and best practices to both prevent and treat these toxicities and symptoms.

The target audience for this symposium includes physicians, researchers, fellows, advanced practice providers, nurses, pharmacists, data managers and other healthcare professionals who provide care for patients undergoing HCT and cellular therapies.

Live Simulcast Available

We are pleased to offer a live simulcast option for the 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy. CME credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; to register, please select the "Live Simulcast" option during course registration.

Call for Abstracts
Submission deadline extended: Saturday, September 14, 2019

The 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy invites the submission of abstracts. Abstracts for the poster session will be selected on the basis of scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted. Top awarded abstracts will receive a travel grant tied to attending this symposium. To submit an abstract, please select the 'Abstract' button above.

Networking Reception & Poster Abstract Session

Course attendees are invited to join the faculty for a networking reception and poster abstract session immediately following the completion of day one, Friday, October 11, from 6:15-7:30 pm in the lobby of Zuckerman Research center. Hors d’oeuvres and refreshments will be served. Please RSVP during course registration.

Objectives

Understand the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
Identify best practices to prevent and treat toxicities and symptom burden after HCT and cellular therapy to improve the patient experience and reduce non-relapse mortality.
Understand how to approach prevention and treatment of toxicities and symptom burden in unique HCT and cellular therapy patient populations.

Registration

Registration Type	Early*	General
Physicians (MDs, PhDs, PharmDs and DOs)	$350	$400
Advanced Practice Providers, Nurses, Data Managers and Other Healthcare Providers	$200	$250
Residents, Fellows	$150	$200
Industry Professionals**	$650	$700
Live Simulcast	-	$600

Course registration includes continental breakfast, lunch, and refreshment breaks (Not applicable to the Live Simulcast). Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

*Early registration rate expires August 31, 2019.
**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration Discounts/Promotions

MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

Live Simulcast registrations are non-refundable.

For all other orders, if you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

In Collaboration With:

UNC Lineberger Comprehensive Cancer Center
American Society for Transplantation and Cellular Therapy (ASTCT)
MD Anderson Cancer Center
Cleveland Clinic
Vanderbilt-Ingram Cancer Center
University of Minnesota
Sarah Cannon Center for Blood Cancer
Johns Hopkins Sidney Kimmel Cancer Center

Image credit: Kandasamy, Biomedical Microscopy Core, Paul D. Coverdell Center

**This live broadcast is for streaming use only. By watching this Simulcast you acknowledge that Memorial Sloan Kettering Cancer Center retains all rights, titles and interest in to all copyrights, trademarks, trade secrets, patents and any other proprietary rights to the content of this material. You are not authorized to record this event. You agree to prevent any unauthorized copying, recording, use, distribution and/or re-broadcast of this live simulcast.

Keywords: